Needham & Company reiterates a 'Buy' on Seattle Genetics (NASDAQ: SGEN), PT $18.

Needham analyst says, "We believe SGEN represents ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE